{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:01:33Z","timestamp":1791306093033,"version":"4.3.1"},"reference-count":74,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ejso.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology (EJSO)"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.ejso.2016.05.010","type":"journal-article","created":{"date-parts":[[2016,5,26]],"date-time":"2016-05-26T17:45:16Z","timestamp":1464284716000},"page":"1772-1779","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["Current and future role of circulating tumor cells in patients with epithelial ovarian cancer"],"prefix":"10.1016","volume":"42","author":[{"given":"C.","family":"Van Berckelaer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.J.","family":"Brouwers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6943-2675","authenticated-orcid":false,"given":"D.J.E.","family":"Peeters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Tjalma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.B.","family":"Trinh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.A.","family":"van Dam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2016.05.010_bib1","series-title":"GLOBOCAN 2012 v1.0, Cancer incidence and mortality Worldwide: IARC CancerBase No. 11 [Internet]","author":"Ferlay","year":"2013"},{"issue":"10 Suppl","key":"10.1016\/j.ejso.2016.05.010_bib2","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.1002\/cncr.11349","article-title":"Incidence of ovarian cancer by race and ethnicity in the United States, 1992\u20131997","volume":"97","author":"Goodman","year":"2003","journal-title":"Cancer"},{"issue":"17","key":"10.1016\/j.ejso.2016.05.010_bib3","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1200\/JCO.2003.02.153","article-title":"Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study","volume":"21","author":"Ozols","year":"2003","journal-title":"J\u00a0Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2016.05.010_bib4","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/j.1525-1438.2005.00130.x","article-title":"CA125 in ovarian cancer: European Group on Tumor Markers guidelines for clinical use","volume":"15","author":"Duffy","year":"2005","journal-title":"Int J Gynecol Cancer Off J Int Gynecol Cancer Soc"},{"issue":"20","key":"10.1016\/j.ejso.2016.05.010_bib5","doi-asserted-by":"crossref","first-page":"5701","DOI":"10.1158\/1078-0432.CCR-12-1587","article-title":"Meta-analysis of the prognostic value of circulating tumor cells in breast cancer","volume":"18","author":"Zhang","year":"2012","journal-title":"Clin Cancer Res An Off J Am Assoc Cancer Res"},{"issue":"7","key":"10.1016\/j.ejso.2016.05.010_bib6","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1245\/s10434-013-2907-8","article-title":"Circulating tumor cells and prognosis of patients with resectable colorectal liver metastases or widespread metastatic colorectal cancer: a meta-analysis","volume":"20","author":"Groot Koerkamp","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1016\/j.ejso.2016.05.010_bib7","doi-asserted-by":"crossref","first-page":"e99259","DOI":"10.1371\/journal.pone.0099259","article-title":"Circulating tumor cells (CTCs) detected by RT-PCR and its prognostic role in gastric cancer: a meta-analysis of published literature","volume":"9","author":"Wang","year":"2014","journal-title":"PloS One"},{"issue":"11","key":"10.1016\/j.ejso.2016.05.010_bib8","doi-asserted-by":"crossref","first-page":"e78070","DOI":"10.1371\/journal.pone.0078070","article-title":"Prognostic significance of circulating tumor cells in non-small-cell lung cancer patients: a meta-analysis","volume":"8","author":"Wang","year":"2013","journal-title":"PloS One"},{"issue":"6","key":"10.1016\/j.ejso.2016.05.010_bib9","doi-asserted-by":"crossref","first-page":"5551","DOI":"10.1007\/s13277-014-1731-5","article-title":"Prognostic role of circulating tumor cells and disseminated tumor cells in patients with prostate cancer: a systematic review and meta-analysis","volume":"35","author":"Ma","year":"2014","journal-title":"Tumour Biol J Int Soc Oncodevelopmental Biol Med"},{"issue":"4","key":"10.1016\/j.ejso.2016.05.010_bib10","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S1470-2045(14)70069-5","article-title":"Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data","volume":"15","author":"Bidard","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2016.05.010_bib11","first-page":"2247","article-title":"One-step detection of circulating tumor cells in ovarian cancer using enhanced fluorescent silica nanoparticles","volume":"8","author":"Kim","year":"2013","journal-title":"Int J Nanomedicine"},{"issue":"3","key":"10.1016\/j.ejso.2016.05.010_bib12","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/0090-8258(90)90088-3","article-title":"Bone marrow involvement in epithelial ovarian cancer by immunocytochemical assessment","volume":"38","author":"Cain","year":"1990","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejso.2016.05.010_bib13","first-page":"38","article-title":"Prognostic value of circulating tumor cells and disseminated tumor cells in patients with ovarian cancer: a systematic review and meta-analysis","volume":"8","author":"Cui","year":"2015","journal-title":"J\u00a0Ovarian Res"},{"issue":"5","key":"10.1016\/j.ejso.2016.05.010_bib14","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ctrv.2009.03.004","article-title":"Circulating tumor cells (CTCs): detection methods and their clinical relevance in breast cancer","volume":"35","author":"Mostert","year":"2009","journal-title":"Cancer Treat Rev"},{"issue":"1","key":"10.1016\/j.ejso.2016.05.010_bib15","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.humpath.2003.08.026","article-title":"Frequent EpCam protein expression in human carcinomas","volume":"35","author":"Went","year":"2004","journal-title":"Hum Pathol"},{"issue":"2","key":"10.1016\/j.ejso.2016.05.010_bib16","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/jcp.21223","article-title":"Epithelial\u2013mesenchymal and mesenchymal\u2013epithelial transitions in carcinoma progression","volume":"213","author":"Hugo","year":"2007","journal-title":"J\u00a0Cell Physiol"},{"issue":"19","key":"10.1016\/j.ejso.2016.05.010_bib17","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1200\/JCO.2007.15.8923","article-title":"Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer","volume":"26","author":"Cohen","year":"2008","journal-title":"J\u00a0Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"8","key":"10.1016\/j.ejso.2016.05.010_bib18","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1056\/NEJMoa040766","article-title":"Circulating tumor cells, disease progression, and survival in metastatic breast cancer","volume":"351","author":"Cristofanilli","year":"2004","journal-title":"N\u00a0Engl J Med"},{"issue":"19","key":"10.1016\/j.ejso.2016.05.010_bib19","doi-asserted-by":"crossref","first-page":"6302","DOI":"10.1158\/1078-0432.CCR-08-0872","article-title":"Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer","volume":"14","author":"de Bono","year":"2008","journal-title":"Clin Cancer Res An Off J Am Assoc Cancer Res"},{"issue":"1","key":"10.1016\/j.ejso.2016.05.010_bib20","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ygyno.2012.09.021","article-title":"Molecular characterization of circulating tumor cells in patients with ovarian cancer improves their prognostic significance \u2013 a study of the OVCAD consortium","volume":"128","author":"Obermayr","year":"2013","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2016.05.010_bib21","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.ygyno.2014.06.013","article-title":"Prognostic analysis of invasive circulating tumor cells (iCTCs) in epithelial ovarian cancer","volume":"134","author":"Pearl","year":"2014","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2016.05.010_bib22","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0002-9440(10)64706-2","article-title":"Isolation by size of epithelial tumor cells : a new method for the immunomorphological and molecular characterization of circulating tumor cells","volume":"156","author":"Vona","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ejso.2016.05.010_bib23","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1186\/1471-2407-10-666","article-title":"Assessment of a six gene panel for the molecular detection of circulating tumor cells in the blood of female cancer patients","volume":"10","author":"Obermayr","year":"2010","journal-title":"BMC Cancer"},{"issue":"7","key":"10.1016\/j.ejso.2016.05.010_bib24","first-page":"1203","article-title":"Isolation, primary culture, morphological and molecular characterization of circulating tumor cells in gynecological cancers","volume":"7","author":"Kolostova","year":"2015","journal-title":"Am J Transl Res"},{"issue":"11","key":"10.1016\/j.ejso.2016.05.010_bib25","first-page":"3363","article-title":"The added value of circulating tumor cells examination in ovarian cancer staging","volume":"5","author":"Kolostova","year":"2015","journal-title":"Am J Cancer Res"},{"issue":"1","key":"10.1016\/j.ejso.2016.05.010_bib26","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ygyno.2008.09.021","article-title":"Clinical significance of circulating tumor cells detected by an invasion assay in peripheral blood of patients with ovarian cancer","volume":"112","author":"Fan","year":"2009","journal-title":"Gynecol Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2016.05.010_bib27","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/sj.bjc.6602418","article-title":"Detection of circulating epithelial cells in the blood of patients with breast cancer: comparison of three techniques","volume":"92","author":"Ring","year":"2005","journal-title":"Br J Cancer"},{"issue":"6","key":"10.1016\/j.ejso.2016.05.010_bib28","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1177\/1758834010378414","article-title":"Circulating tumour cells: their utility in cancer management and predicting outcomes","volume":"2","author":"Krebs","year":"2010","journal-title":"Ther Adv Med Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2016.05.010_bib29","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1097\/IGC.0b013e318216cb91","article-title":"Molecular profiling and prognostic relevance of circulating tumor cells in the blood of ovarian cancer patients at primary diagnosis and after platinum-based chemotherapy","volume":"21","author":"Aktas","year":"2011","journal-title":"Int J Gynecol Cancer Off J Int Gynecol Cancer Soc"},{"issue":"10","key":"10.1016\/j.ejso.2016.05.010_bib30","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1373\/clinchem.2014.224808","article-title":"ERCC1-positive circulating tumor cells in the blood of ovarian cancer patients as a predictive biomarker for platinum resistance","volume":"60","author":"Kuhlmann","year":"2014","journal-title":"Clin Chem"},{"key":"10.1016\/j.ejso.2016.05.010_bib31","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.cca.2014.02.019","article-title":"Improvement of specific detection of circulating tumor cells using combined CD45 staining and fluorescence in situ hybridization","volume":"433","author":"Ning","year":"2014","journal-title":"Clin Chimica Acta Int J Clin Chem"},{"issue":"1","key":"10.1016\/j.ejso.2016.05.010_bib32","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ccr.2014.05.002","article-title":"Hematogenous metastasis of ovarian cancer: rethinking mode of spread","volume":"26","author":"Pradeep","year":"2014","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.ejso.2016.05.010_bib33","doi-asserted-by":"crossref","first-page":"e0130873","DOI":"10.1371\/journal.pone.0130873","article-title":"Prognostic value of circulating tumor cells in ovarian cancer: a meta-analysis","volume":"10","author":"Zhou","year":"2015","journal-title":"PloS One"},{"issue":"12","key":"10.1016\/j.ejso.2016.05.010_bib34","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1200\/JCO.2010.34.0026","article-title":"Circulating tumor cells: not all detected cells are bad and not all bad cells are detected","volume":"29","author":"Wicha","year":"2011","journal-title":"J\u00a0Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2016.05.010_bib35","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.ygyno.2013.08.006","article-title":"Predictive value of circulating tumor cells (CTCs) in newly-diagnosed and recurrent ovarian cancer patients","volume":"131","author":"Liu","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejso.2016.05.010_bib36","doi-asserted-by":"crossref","unstructured":"Sang M, Wu X, Fan X, Sang M, Zhou X, Zhou N. Multiple MAGE-A genes as surveillance marker for the detection of circulating tumor cells in patients with ovarian cancer. Biomarkers: biochemical indicators of exposure, response, and susceptibility to chemicals 2014; 19(1):34\u201342.","DOI":"10.3109\/1354750X.2013.865275"},{"issue":"2","key":"10.1016\/j.ejso.2016.05.010_bib37","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ygyno.2003.08.004","article-title":"Preoperative detection of peripherally circulating cancer cells and its prognostic significance in ovarian cancer","volume":"91","author":"Judson","year":"2003","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2016.05.010_bib38","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.ygyno.2011.05.028","article-title":"Circulating tumor cells predict progression free survival and overall survival in patients with relapsed\/recurrent advanced ovarian cancer","volume":"122","author":"Poveda","year":"2011","journal-title":"Gynecol Oncol"},{"issue":"20","key":"10.1016\/j.ejso.2016.05.010_bib39","doi-asserted-by":"crossref","first-page":"4051","DOI":"10.1200\/JCO.2004.10.028","article-title":"Should CA-125 response criteria be preferred to response evaluation criteria in solid tumors (RECIST) for prognostication during second-line chemotherapy of ovarian carcinoma?","volume":"22","author":"Gronlund","year":"2004","journal-title":"J\u00a0Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2016.05.010_bib40","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ygyno.2015.03.002","article-title":"Treatment monitoring of patients with epithelial ovarian cancer using invasive circulating tumor cells (iCTCs)","volume":"137","author":"Pearl","year":"2015","journal-title":"Gynecol Oncol"},{"issue":"6","key":"10.1016\/j.ejso.2016.05.010_bib41","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1593\/tlo.12247","article-title":"Interpretation of changes in circulating tumor cell counts","volume":"5","author":"Coumans","year":"2012","journal-title":"Transl Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2016.05.010_bib42","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ygyno.2011.06.022","article-title":"Phase II trial of the mTOR inhibitor, temsirolimus and evaluation of circulating tumor cells and tumor biomarkers in persistent and recurrent epithelial ovarian and primary peritoneal malignancies: a Gynecologic Oncology Group study","volume":"123","author":"Behbakht","year":"2011","journal-title":"Gynecol Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2016.05.010_bib43","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1056\/NEJMoa0800668","article-title":"Detection of mutations in EGFR in circulating lung-cancer cells","volume":"359","author":"Maheswaran","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.ejso.2016.05.010_bib44","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1245\/s10434-009-0831-8","article-title":"Enhancing detection of circulating tumor cells with activating KRAS oncogene in patients with colorectal cancer by weighted chemiluminescent membrane array method","volume":"17","author":"Yang","year":"2010","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"10.1016\/j.ejso.2016.05.010_bib45","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1158\/0008-5472.CAN-08-3667","article-title":"Characterization of ERG, AR and PTEN gene status in circulating tumor cells from patients with castration-resistant prostate cancer","volume":"69","author":"Attard","year":"2009","journal-title":"Cancer Res"},{"issue":"11","key":"10.1016\/j.ejso.2016.05.010_bib46","doi-asserted-by":"crossref","first-page":"3600","DOI":"10.1158\/1078-0432.CCR-11-0255","article-title":"mRNA and microRNA expression profiles in circulating tumor cells and primary tumors of metastatic breast cancer patients","volume":"17","author":"Sieuwerts","year":"2011","journal-title":"Clin Cancer Res An Off J Am Assoc Cancer Res"},{"issue":"5","key":"10.1016\/j.ejso.2016.05.010_bib47","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/annonc\/mds625","article-title":"Unbiased quantitative assessment of Her-2 expression of circulating tumor cells in patients with metastatic and non-metastatic breast cancer","volume":"24","author":"Ligthart","year":"2013","journal-title":"Ann Oncol Off J Eur Soc Med Onco\/ESMO"},{"issue":"3","key":"10.1016\/j.ejso.2016.05.010_bib48","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.molonc.2013.02.013","article-title":"Monitoring apoptosis and Bcl-2 on circulating tumor cells in patients with metastatic breast cancer","volume":"7","author":"Smerage","year":"2013","journal-title":"Mol Oncol"},{"issue":"Pt 1","key":"10.1016\/j.ejso.2016.05.010_bib49","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1042\/bj3410127","article-title":"Evidence that cyclophilin-A protects cells against oxidative stress","volume":"341","author":"Doyle","year":"1999","journal-title":"Biochem J"},{"issue":"3","key":"10.1016\/j.ejso.2016.05.010_bib50","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s10549-008-0290-0","article-title":"Molecular characterization of circulating tumor cells in large quantities of contaminating leukocytes by a multiplex real-time PCR","volume":"118","author":"Sieuwerts","year":"2009","journal-title":"Breast Cancer Res Treat"},{"issue":"6","key":"10.1016\/j.ejso.2016.05.010_bib51","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1038\/bjc.2013.92","article-title":"Semiautomated isolation and molecular characterisation of single or highly purified tumour cells from CellSearch enriched blood samples using dielectrophoretic cell sorting","volume":"108","author":"Peeters","year":"2013","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.ejso.2016.05.010_bib52","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1475-2867-14-23","article-title":"Stabilization of circulating tumor cells in blood using a collection device with a preservative reagent","volume":"14","author":"Qin","year":"2014","journal-title":"Cancer Cell Int"},{"issue":"1","key":"10.1016\/j.ejso.2016.05.010_bib53","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/nprot.2014.006","article-title":"Full-length RNA-seq from single cells using Smart-seq2","volume":"9","author":"Picelli","year":"2014","journal-title":"Nat Protoc"},{"issue":"3","key":"10.1016\/j.ejso.2016.05.010_bib54","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/nprot.2009.236","article-title":"RNA-Seq analysis to capture the transcriptome landscape of a single cell","volume":"5","author":"Tang","year":"2010","journal-title":"Nat Protoc"},{"issue":"7467","key":"10.1016\/j.ejso.2016.05.010_bib55","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/nature12625","article-title":"The causes and consequences of genetic heterogeneity in cancer evolution","volume":"501","author":"Burrell","year":"2013","journal-title":"Nature"},{"issue":"1\u20132","key":"10.1016\/j.ejso.2016.05.010_bib56","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s10555-012-9398-0","article-title":"Clinical application of circulating tumor cells in breast cancer: overview of the current interventional trials","volume":"32","author":"Bidard","year":"2013","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.ejso.2016.05.010_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.ygyno.2016.03.037","article-title":"Targeting the hallmarks of ovarian cancer: the big picture","author":"Petrillo","year":"2016","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejso.2016.05.010_bib58","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.8015","article-title":"Evaluation and consequences of heterogeneity in the circulating tumor cell compartment","author":"Brouwer","year":"2016","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.ejso.2016.05.010_bib59","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/nrc1886","article-title":"Metastasis: a question of life or death","volume":"6","author":"Mehlen","year":"2006","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"10.1016\/j.ejso.2016.05.010_bib60","doi-asserted-by":"crossref","first-page":"519","DOI":"10.2217\/whe.14.37","article-title":"Ovarian cancer: diagnostic, biological and prognostic aspects","volume":"10","author":"Davidson","year":"2014","journal-title":"Women's Health"},{"issue":"6","key":"10.1016\/j.ejso.2016.05.010_bib61","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1200\/JCO.2010.33.8889","article-title":"Loss of human epidermal growth factor receptor 2 (HER2) expression in metastatic sites of HER2-overexpressing primary breast tumors","volume":"30","author":"Niikura","year":"2012","journal-title":"J\u00a0Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"12","key":"10.1016\/j.ejso.2016.05.010_bib62","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.1158\/1078-0432.CCR-11-2696","article-title":"Detection of tumor PIK3CA status in metastatic breast cancer using peripheral blood","volume":"18","author":"Higgins","year":"2012","journal-title":"Clin Cancer Res An Off J Am Assoc Cancer Res"},{"issue":"7","key":"10.1016\/j.ejso.2016.05.010_bib63","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1158\/1078-0432.CCR-13-2332","article-title":"Emergence of constitutively active estrogen receptor-alpha mutations in pretreated advanced estrogen receptor-positive breast cancer","volume":"20","author":"Jeselsohn","year":"2014","journal-title":"Clin Cancer Res An Off J Am Assoc Cancer Res"},{"issue":"5","key":"10.1016\/j.ejso.2016.05.010_bib64","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/nrc3261","article-title":"Intra-tumour heterogeneity: a looking glass for cancer?","volume":"12","author":"Marusyk","year":"2012","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"10.1016\/j.ejso.2016.05.010_bib65","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1200\/JCO.2012.45.2011","article-title":"Liquid biopsies: genotyping circulating tumor DNA","volume":"32","author":"Diaz","year":"2014","journal-title":"J\u00a0Clin Oncol Off J Am Soc Clin Oncol"},{"key":"10.1016\/j.ejso.2016.05.010_bib66","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1196\/annals.1368.031","article-title":"Quantification of total plasma cell-free DNA in ovarian cancer using real-time PCR","volume":"1075","author":"Kamat","year":"2006","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"10.1016\/j.ejso.2016.05.010_bib67","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1593\/neo.131900","article-title":"Personalized ovarian cancer disease surveillance and detection of candidate therapeutic drug target in circulating tumor DNA","volume":"16","author":"Martignetti","year":"2014","journal-title":"Neoplasia"},{"issue":"12","key":"10.1016\/j.ejso.2016.05.010_bib68","doi-asserted-by":"crossref","first-page":"e0145754","DOI":"10.1371\/journal.pone.0145754","article-title":"Personalized circulating tumor DNA biomarkers dynamically predict treatment response and survival in gynecologic cancers","volume":"10","author":"Pereira","year":"2015","journal-title":"PloS One"},{"issue":"12","key":"10.1016\/j.ejso.2016.05.010_bib69","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1093\/annonc\/mdu480","article-title":"Circulating tumor cells and circulating tumor DNA for precision medicine: dream or reality?","volume":"25","author":"Ignatiadis","year":"2014","journal-title":"Ann Oncol Off J Eur Soc Med Oncol\/ESMO"},{"issue":"6","key":"10.1016\/j.ejso.2016.05.010_bib70","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/nbt.2576","article-title":"Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay","volume":"31","author":"Baccelli","year":"2013","journal-title":"Nat Biotechnol"},{"issue":"10","key":"10.1016\/j.ejso.2016.05.010_bib71","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1158\/0008-5472.CAN-12-4140","article-title":"Complex tumor genomes inferred from single circulating tumor cells by array-CGH and next-generation sequencing","volume":"73","author":"Heitzer","year":"2013","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.ejso.2016.05.010_bib72","doi-asserted-by":"crossref","first-page":"448","DOI":"10.3892\/ol.2013.1364","article-title":"Fluid biopsy for circulating tumor cells in an occult ovarian cancer patient exhibiting bilateral supraclavicular lymph node metastases: a case report","volume":"6","author":"He","year":"2013","journal-title":"Oncol Lett"},{"key":"10.1016\/j.ejso.2016.05.010_bib73","doi-asserted-by":"crossref","first-page":"819362","DOI":"10.1155\/2014\/819362","article-title":"Detection of circulating tumor cells","volume":"2014","author":"de Wit","year":"2014","journal-title":"Scientifica"},{"issue":"3","key":"10.1016\/j.ejso.2016.05.010_bib74","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/cncr.10250","article-title":"Circulating tumor cells in the peripheral blood and bone marrow of patients with ovarian carcinoma do not predict prognosis","volume":"94","author":"Marth","year":"2002","journal-title":"Cancer"}],"container-title":["European Journal of Surgical Oncology (EJSO)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798316301603?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798316301603?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,8]],"date-time":"2019-09-08T19:06:03Z","timestamp":1567969563000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798316301603"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":74,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S0748798316301603"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2016.05.010","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current and future role of circulating tumor cells in patients with epithelial ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology (EJSO)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2016.05.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}